Skip to main content
. 2021 Mar 9;2021(3):CD013522. doi: 10.1002/14651858.CD013522.pub2

Pawlina 2015.

Study characteristics
Methods Study design: longitudinal cohort
Country: Brazil
Data collection period: May 2012 – August 2012
Registry ID: N/A (cohort)
Participants Number of participants: N = 142
Sample characteristics (at baseline):
Age (mean): mean not reported, 64% between 40 ‐ 59 years; Sex (% male): 29.6% (42/142)
Population category: general population; Specific population: participants spontaneously sought out the smoking cessation programme at 1 of 4 healthcare facilities in the city of Cuiabá, Brazil
Nicotine dependence: 98/142 (69%) had a FTND score ≥ 6 (indicating high or very high nicotine dependence); Baseline cigarettes per day: 56 (39.4%) smoked 11 ‐ 20 cigarettes/day; Motivation to quit: selected by motivation to quit
Interventions Behavioural support for smoking cessation: all participants were treated with the same protocol ‐ nicotine replacement therapy, bupropion and CBT; at the initial session participants were submitted to an initial psychological evaluation by a psychologist, who counselled them in relation to the proposed treatment plan, and scheduled the first CBT session; participants were invited to attend 4 weekly 90‐minute group CBT sessions (10 ‐ 15 participants each); participants were also offered the option to attend 5 follow‐up sessions, at 15, 30, 60, 90, and 180 days after the initial 4‐week treatment period
Pharmacological support for smoking cessation: during the initial interview, the participants were evaluated by the physician responsible for the programme and subsequently received the appropriate medication; states participants received nicotine replacement therapy and bupropion – no further details
Psychotherapeutic or psychoactive support for mental health or mood: received mood management – states all participants received bupropion
Outcomes Definition of cessation used: exact definition not reported; ‘able to quit smoking’
Cessation definition used for outcome(s) in this analysis: unclear definition
Measure of biovalidation: not bioverified
Definition of people who continued to smoke used: exact definition not reported; ‘those who continued to smoke’
Time point(s) at which follow‐up was conducted: 45 days, 6 months
Outcome category: Anxiety, Depression, Stress
Outcome measure(s): Beck Anxiety Inventory (BAI); Beck Depression Inventory (BDI); Lipp Inventory of Stress Symptoms for Adults
Funding source None
Author conflicts of interest None specified
Notes Outcome data source: Published data